Gene Huang

Gene has a 30+ year career building health care businesses, focusing on health services companies, health plans, provider organizations, and most recently payment reform and value based care initiatives in the post acute setting for skilled nursing facilities. Gene managed home health care, and home IV therapy businesses, was COO of OptiCare Eye Health, and was President and Chief Development officer of a multi-state physician home visit company that was sold to CIGNA. In the health plan sector, he built the Medicare Advantage business from start up to an $850 million unit of Oxford Health Plans in the CT/NY/NJ market, was CEO of Citrus HealthCare in Tampa in a turnaround / ownership transition, ran the Medicare Advantage plan for HealthNet of the Northeast, built Chronic Special Needs Plans for Aveta, and ran the nationwide 24 hour nurse line for IntraCorp / CIGNA HealthCare. Over the last six years Gene led the post acute business for Remedy Partners, the largest player in the CMS Bundled Payment for Care Improvement program, generating substantial savings for Medicare, surpluses for SNF partners, and returns for investors.

Gene is also an active investor in healthcare ventures, investing directly, and as a partner in two Private Equity funds, Ferrer Freeman and Company, and Health Catalyst Capital where he is also an Advisor. He has had Board roles in Pulse8, a healthcare analytics venture, and currently with ReferWell, a cloud based referral management company, and has helped drive business development and sales for SaaS based healthcare ventures.